Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 43,847 | 89,046 | 56,206 | 37,944 | 34,755 |
| Cost of Goods | 9,622 | 12,003 | 13,721 | 9,202 | 6,611 |
| Gross Profit | 34,225 | 77,043 | 42,485 | 28,742 | 28,144 |
| Operating Expenses | 138,453 | 132,250 | 266,151 | 206,946 | 206,872 |
| Operating Income | -103,606 | -55,204 | -222,945 | -178,002 | -178,117 |
| Other Income | -4,253 | -1,574 | 5,954 | 12,122 | -33,775 |
| Pre-tax Income | -107,859 | -56,778 | -216,991 | -165,880 | -211,892 |
| Income Tax | -325 | -375 | 190 | 31 | -198 |
| Net Income Continuous | -107,534 | -56,403 | -217,181 | -165,911 | -211,694 |
| Net Income | $-107,534 | $-56,403 | $-217,181 | $-165,911 | $-211,694 |
| EPS Basic Total Ops | -1.92 | -1.08 | -4.23 | -3.31 | -4.16 |
| EPS Basic Continuous Ops | -1.92 | -1.08 | -4.23 | -3.31 | -4.29 |
| EPS Diluted Total Ops | -1.91 | -1.08 | -4.23 | -3.32 | -4.16 |
| EPS Diluted Continuous Ops | -1.92 | -1.08 | -4.23 | -3.31 | -4.29 |
| EPS Diluted Before Non-Recurring Items | -1.82 | -1.08 | -3.20 | N/A | N/A |
| EBITDA(a) | $-87,954 | $-38,035 | $-157,757 | $-165,133 | $-165,280 |